Health After Birth Intervention Trial (HABIT)

October 19, 2022 updated by: Ashleigh Graham, Queen Margaret University

A Feasibility RCT Investigating the Effect of a Kilocalorie Controlled, Low Carbohydrate Dietary Intervention, Behavioural Modification and Telehealth vs a Standard 1:1 NHS Weight Management Programme in Post-partum Women Living With Obesity

This trial is to assess the feasibility of a larger, definitive RCT and determine the clinical effectiveness of an NHS 1:1 programme versus a modified programme with a low carbohydrate dietary intervention (as per Feinman and colleagues classification) with telehealth, physical activity and enhanced behaviour change on specified health outcomes amongst post-partum women living with obesity

Study Overview

Detailed Description

For individuals living with obesity, the post-partum period is currently the initial, optimal timeframe for weight management. Many women reconceive during the post-partum phase, increasing the risk of between-pregnancy bodyweight retention and even gain. Consequentially, many re-enter subsequent pregnancies with a higher BMI often associated with unfavourable obstetric outcome and further cyclical perpetuation.

Health behaviour change is an important facet within weight management interventions and delivery may be enhanced by digital technologies, for example, telehealth. Short messaging service (SMS) may be used to enhance communication between patients and practitioner and is relatively inexpensive to use.

Low carbohydrate diets continue to gain traction however research is arguably confounded by the lack of a universally agreed definition and classification. Feinman and colleagues (2015) propose intermediary categories. The experimental arm of this trial will be encouraged to adopt a non-ketogenic LCD as per Feinman.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Edinburgh, United Kingdom, EH9 2HL
        • Astley Ainslie Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Adult aged 18 or above
  • Ready and motivated to make lifestyle changes
  • Have a Body Mass Index of ≥30 kg/m2 (at initial booking appointment)

Additional study specific criteria

  • English speaking and ability to read English language
  • Capacity to consent to participating in the study
  • Are non-diabetic or those with Type 2 diabetes which is diet controlled
  • Deemed medically fit by GP/medical professional to participate via email
  • Have recently given birth (within 1 year)
  • Are not receiving weight management support elsewhere e.g. NHS, Scottish slimmers, weight watchers
  • Have access to a mobile phone and weighing scales

Exclusion Criteria:

  • Have uncontrolled hypothyroidism
  • Have unstable psychosis or severe and unstable personality disorder
  • Are pregnant
  • Have dementia
  • Have moderate to severe learning disability or learning difficulty which impairs the ability to adhere to the programme (identified by medical history and confirmed with GP)
  • Current alcohol or substance misuse (6 month period of abstinence)
  • Active purging
  • Bulimia Nervosa
  • Binge Eating Disorder

Additional study specific criteria

  • Known cancers
  • Type 1 Diabetes or Type 2 Diabetes on any Diabetic medication (including Insulin)
  • Have a pacemaker
  • Renal impairment
  • Taking Orlistat or any other weight loss medication or had previous bariatric surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Adapted NHS weight management 1:1 programme. Low carbohydrate dietary focus, enhanced behaviour change via telehealth, daily step target supported by pedometers
Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer
Active Comparator: Active comparator NHS 1:1 weight management programme
12 week NHS 1:1 weight management programme
NHS 1:1 weight management programme

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Bodyweight (Kilograms)
Time Frame: Proposed 0,3,6,8 months
Bodyweight measured by the CI or self-reported
Proposed 0,3,6,8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body composition (Fat mass/fat free mass)
Time Frame: Proposed 0,3,6,8 months
Medical grade
Proposed 0,3,6,8 months
Change in Waist circumference (Centimetres)
Time Frame: Proposed 0,3,6,8 months
SECA Ergonomic measuring tape
Proposed 0,3,6,8 months
Change in systolic and diastolic Blood pressure
Time Frame: Proposed 0,3,6,8 months
Standard technique
Proposed 0,3,6,8 months
Change in Physical activity levels
Time Frame: Proposed 0,3,6,8 months
Level of physical activity (minutes) and step count from pedometer data
Proposed 0,3,6,8 months
Change in emotional eating using the Weight loss Readiness Test II
Time Frame: 0,3,6,8 months
Incidence of emotional eating (if present) determined by change score. Increased score is less favourable
0,3,6,8 months
Change in hunger and eating cues using the Weight loss Readiness Test II
Time Frame: 0,3,6,8 months
Hunger and eating cues determined by change score. Increased score is less favourable
0,3,6,8 months
Change in psychological distress (if present) using the Clinical Outcomes in Routine Evaluation-10 screening tool
Time Frame: Baseline, post-intervention at 3 months
Measured using the Clinical Outcomes in Routine Evaluation-10 tool using change scores. An increased score is less favourable
Baseline, post-intervention at 3 months
Change in Quality of life
Time Frame: Proposed 0,3,6,8 months
Measured using the World Health Organisation Quality of life (BREF) tool. A lower score is less favourable
Proposed 0,3,6,8 months
Food frequency questionnaire
Time Frame: Baseline
Standard validated tool
Baseline
Diet quality
Time Frame: Proposed 0,3,6,8 months
Diet quality measured using a 3 day unweighed food diary
Proposed 0,3,6,8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Ashleigh Graham, Queen Margaret University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2022

Primary Completion (Actual)

September 15, 2022

Study Completion (Actual)

September 15, 2022

Study Registration Dates

First Submitted

October 18, 2021

First Submitted That Met QC Criteria

November 29, 2021

First Posted (Actual)

November 30, 2021

Study Record Updates

Last Update Posted (Actual)

October 21, 2022

Last Update Submitted That Met QC Criteria

October 19, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 10052021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Only anonymised data will be accessible by the rest of the current research team for purpose of statistical analysis and monitoring

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Adapted NHS weight management 1:1 programme

Subscribe